Purple Biotech Reports Positive Final Results From Randomized Phase 2 Study of Cm24 in Second Line Pancreatic Cancer
紫色生物科技公佈Cm24在胰腺癌二線治療中隨機2期研究的積極最終結果
Purple Biotech Reports Positive Final Results From Randomized Phase 2 Study of Cm24 in Second Line Pancreatic Cancer
紫色生物科技公佈Cm24在胰腺癌二線治療中隨機2期研究的積極最終結果
使用瀏覽器的分享功能,分享給你的好友吧